NRX Pharmaceuticals (NRXP) Assets (2017 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly Assets of $11.9 million for Q1 2026, up 56.82% year-over-year from $7.6 million in Q1 2025, and down 8.13% quarter-over-quarter from $13.0 million in Q4 2025.
NRX Pharmaceuticals (NRXP) Assets (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Assets for 10 consecutive years, with $11.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 56.82% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $11.9 million (up 56.82% YoY), while the FY2025 annual figure was $13.0 million, up 254.86% from the prior year.
- Assets declined to $11.9 million in Q1 2026 per NRXP's latest filing, from $13.0 million in the prior quarter.
- Across five years, Assets topped out at $43.6 million in Q1 2022 and bottomed at $3.7 million in Q4 2024.
- Historically, Assets has averaged $15.2 million across 5 years, with a median of $13.0 million in 2025.
- Annual changes were most pronounced in 2022 — Assets surged 623.34% — and 2024, when it plunged 82.61%.
- NRX Pharmaceuticals' Assets stood at $25.8 million in 2022, then tumbled by 71.66% to $7.3 million in 2023, then sank by 50.09% to $3.7 million in 2024, then jumped by 254.86% to $13.0 million in 2025, then retreated by 8.13% to $11.9 million in 2026.
- Business Quant data shows NRXP's Assets at $11.9 million in Q1 2026, $13.0 million in Q4 2025, and $15.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 19.82 Bn |
| 10 | NRX Pharmaceuticals | 133.97 Mn | 107.27 Mn | 426,000.00 | 34.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.90 Mn |
| Dec 31, 2025 | 12.96 Mn |
| Sep 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 4.84 Mn |
| Mar 31, 2025 | 7.59 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 4.46 Mn |
| Jun 30, 2024 | 5.26 Mn |
| Mar 31, 2024 | 3.79 Mn |
| Dec 31, 2023 | 7.32 Mn |
| Sep 30, 2023 | 13.11 Mn |
| Jun 30, 2023 | 19.81 Mn |
| Mar 31, 2023 | 21.78 Mn |
| Dec 31, 2022 | 25.82 Mn |
| Sep 30, 2022 | 24.82 Mn |
| Jun 30, 2022 | 32.43 Mn |
| Mar 31, 2022 | 43.60 Mn |
| Dec 31, 2021 | 32.73 Mn |
| Sep 30, 2021 | 45.25 Mn |
| Jun 30, 2021 | 18.55 Mn |